tirzepatide and not losing weight 7 Reasons You Aren't on Weight Loss Drugs Tirzepatide Weight Loss Plateau: Why

However, given the retrospective design and baseline heterogeneity between groups, these results should be interpreted as associations rather than definitive evidence of superiority

Some patients taking semaglutide have reported kidney-related side effects, such as increased creatinine levels (a marker of kidney function) and acute kidney injury

GLP-1 receptor agonists may increase hypoglycaemia risk when used alongside insulin or sulfonylureas Determine whether you meet NHS eligibility criteria or require referral to a specialist weight management service Provide ongoing monitoring, including weight, blood pressure, blood glucose, and where relevant INR or thyroid function For individuals with type 2 diabetes or established cardiovascular disease , injectable GLP-1 receptor agonists may offer additional clinical benefits beyond weight loss, including improved glycaemic control

It is important to be patient as some people may not experience weight loss in the first 4-8 weeks

People forget theirs every single time